Table 1.
Demographic characteristics of each group of participants.
| Patients | Controls | Group effect | |
|---|---|---|---|
| Gender M/F | 23/5 | 18/6 | Chi² < 1, n.s. |
| Age (mean+/−SD) | 31,0 (+/−7,9) | 30,6 (+/−8,4) | F < 1, n.s. |
| Years of education (mean+/−SD) | 12, 6 (+/−1,9) | 13,6 (+/−1,8) | F[1,50] = 3.6, n.s. |
| Medication (typical, atypical, no medication) | 0/25/3 | ||
| Mean+/−SD dose of chlorpromazine equivalents / patient | 289 mg/day (+/−252) | ||
| PANSS positive symptoms (mean+/−SD) | 15,2 (+/−5,5) | ||
| PANSS negative symptoms (mean+/−SD) | 20,8 (+/−8,2) | ||
| PANSS general symptoms (mean+/−SD) | 38,9 (+/−11,7) | ||
| PANSS total (mean+/−SD) | 74,1 (+/−22,3) | ||
| EASE ‘Cognition and stream of consciousness’ (mean+/−SD) maximum = 17 | 6,6 (+/−3,9) | ||
| EASE ‘Self-awareness and presence’ (mean+/−SD) maximum = 18 | 4,8 (+/−3) | ||
| EASE ‘Bodily experiences’ (mean+/−SD) maximum = 9 | 1,6 (+/−1,5) | ||
| EASE ‘Demarcation – transitivism’ (mean+/−SD) maximum = 5 | 1 (+/−0,9) | ||
| EASE ‘Existential reorientation’ (mean+/−SD) maximum = 8 | 1,4 (+/−1,4) | ||
| EASE total (mean+/−SD)- maximum = 57 | 15,4 (+/−7,7) |